Option Care Health, Inc. (OPCH) P/E Ratio History
Fairly ValuedTrading at 22.1x, near 5Y avg of 25.8x · 30th percentile · In line with own history · Data 1998–2026
Loading P/E history...
P/E Ratio Analysis
As of November 8, 2026, Option Care Health, Inc. (OPCH) trades at a price-to-earnings ratio of 22.1x, with a stock price of $31.65 and trailing twelve-month earnings per share of $1.43.
The current P/E is 14% below its 5-year average of 25.8x. Over the past five years, OPCH's P/E has ranged from a low of 15.8x to a high of 36.7x, placing the current valuation at the 30th percentile of its historical range.
Compared to the Healthcare sector median P/E of 24.6x, OPCH is roughly in line with its sector peers. The sector includes 242 companies with P/E ratios ranging from 0.0x to 196.0x.
Relative to the broader market, OPCH trades roughly in line with the S&P 500 median P/E of 21.8x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our OPCH DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
OPCH Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
OPCH P/E vs Peers
Home Health & Hospice peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $1B | 36.9 | 3.66 | +18% | |
| $2B | 16.1 | - | +53% | |
| $1B | 136.7 | - | +92% | |
| $107B | 9.8Lowest | - | -62% | |
| $124B | 26.3 | - | +49% | |
| $64B | 34.8 | 1.23 | +12% | |
| $65B | 18.4 | 0.95Best | +126%Best | |
| $248B | 26.8 | 9.10 | +88% |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
OPCH Historical P/E Data (1998–2026)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2026 Q3 | Sep 30 2026 | $22.49 | $1.39 | 16.2x | -68% |
| FY2026 Q2 | - | $20.97 | $1.33 | 15.8x | -68% |
| FY2026 Q1 | - | $26.92 | $1.29 | 20.9x | -58% |
| FY2025 Q4 | Dec 31 2025 | $31.86 | $1.28 | 24.9x | -50% |
| FY2025 Q3 | - | $27.76 | $1.26 | 22.0x | -56% |
| FY2025 Q2 | Jun 30 2025 | $32.48 | $1.25 | 26.0x | -48% |
| FY2025 Q1 | Mar 31 2025 | $34.95 | $1.24 | 28.2x | -44% |
| FY2024 Q4 | - | $23.20 | $1.22 | 19.0x | -62% |
| FY2024 Q3 | Sep 30 2024 | $31.30 | $1.19 | 26.3x | -47% |
| FY2024 Q2 | Jun 30 2024 | $27.70 | $1.19 | 23.3x | -53% |
| FY2024 Q1 | Mar 31 2024 | $33.54 | $1.52 | 22.1x | -56% |
| FY2023 Q4 | Dec 31 2023 | $33.69 | $1.47 | 22.9x | -54% |
| FY2023 Q3 | Sep 30 2023 | $32.35 | $1.41 | 22.9x | -54% |
| FY2023 Q2 | Jun 30 2023 | $32.49 | $1.31 | 24.8x | -50% |
| FY2023 Q1 | Mar 31 2023 | $31.77 | $0.87 | 36.5x | -27% |
| FY2022 Q4 | Dec 31 2022 | $30.09 | $0.83 | 36.3x | -27% |
| FY2022 Q3 | Sep 30 2022 | $31.47 | $0.98 | 32.1x | -36% |
| FY2022 Q2 | - | $27.79 | $0.97 | 28.6x | -43% |
| FY2022 Q1 | - | $28.56 | $0.96 | 29.8x | -40% |
| FY2021 Q4 | Dec 31 2021 | $28.44 | $0.77 | 36.7x | -26% |
| FY2021 Q3 | - | $24.26 | $0.46 | 52.3x | +5% |
| FY2021 Q2 | Jun 30 2021 | $21.87 | $0.27 | 79.8x | +60% |
| FY2021 Q1 | Mar 31 2021 | $17.74 | $0.05 | 349.9x | +600% |
| FY2013 Q1 | Mar 31 2013 | $50.84 | $4.26 | 11.9x | -76% |
| FY2012 Q4 | Dec 31 2012 | $43.08 | $4.63 | 9.3x | -81% |
| FY2012 Q3 | Sep 30 2012 | $36.44 | $4.64 | 7.9x | -84% |
| FY2012 Q2 | Jun 30 2012 | $29.72 | $5.49 | 5.4x | -89% |
| FY2012 Q1 | Mar 31 2012 | $27.16 | $0.16 | 169.8x | +240% |
| FY2011 Q4 | Dec 31 2011 | $21.84 | $0.56 | 39.0x | -22% |
| FY2010 Q3 | - | $20.64 | $3.69 | 5.6x | -89% |
| FY2010 Q2 | Jun 30 2010 | $20.96 | $4.09 | 5.1x | -90% |
| FY2010 Q1 | Mar 31 2010 | $31.96 | $4.29 | 7.4x | -85% |
| FY2009 Q4 | - | $33.44 | $5.31 | 6.3x | -87% |
| FY2008 Q3 | - | $11.92 | $0.53 | 22.5x | -55% |
| FY2008 Q2 | Jun 30 2008 | $10.36 | $0.53 | 19.5x | -61% |
| FY2008 Q1 | Mar 31 2008 | $27.04 | $0.41 | 66.0x | +32% |
| FY2007 Q4 | Dec 31 2007 | $30.92 | $0.32 | 96.6x | +93% |
| FY2005 Q3 | Sep 30 2005 | $26.00 | $0.13 | 200.0x | +300% |
| FY2005 Q2 | - | $24.00 | $0.37 | 64.9x | +30% |
| FY2005 Q1 | - | $24.12 | $1.11 | 21.7x | -57% |
| FY2004 Q4 | Dec 31 2004 | $25.44 | $1.27 | 20.0x | -60% |
| FY2004 Q3 | - | $23.04 | $1.25 | 18.4x | -63% |
| FY2004 Q2 | Jun 30 2004 | $34.80 | $1.17 | 29.7x | -40% |
| FY2004 Q1 | Mar 31 2004 | $30.44 | $1.45 | 21.0x | -58% |
| FY2003 Q4 | Dec 31 2003 | $28.12 | $1.65 | 17.0x | -66% |
| FY2003 Q3 | - | $30.00 | $2.24 | 13.4x | -73% |
| FY2003 Q2 | Jun 30 2003 | $26.08 | $2.76 | 9.4x | -81% |
| FY2003 Q1 | Mar 31 2003 | $29.68 | $2.88 | 10.3x | -79% |
| FY2002 Q4 | - | $23.20 | $3.16 | 7.3x | -85% |
| FY2002 Q3 | Sep 30 2002 | $37.80 | $3.00 | 12.6x | -75% |
| FY2002 Q2 | Jun 30 2002 | $48.36 | $3.00 | 16.1x | -68% |
| FY2002 Q1 | Mar 31 2002 | $66.00 | $2.84 | 23.2x | -53% |
| FY2001 Q4 | Dec 31 2001 | $71.20 | $2.64 | 27.0x | -46% |
| FY2001 Q3 | Sep 30 2001 | $42.00 | $1.30 | 32.3x | -35% |
| FY2001 Q2 | Jun 30 2001 | $24.00 | $0.58 | 41.4x | -17% |
| FY2001 Q1 | Mar 31 2001 | $10.13 | $0.22 | 46.0x | -8% |
| FY1999 Q3 | - | $8.50 | $0.01 | 850.0x | +1601% |
| FY1999 Q2 | Jun 30 1999 | $9.75 | $0.45 | 21.7x | -57% |
| FY1999 Q1 | Mar 31 1999 | $9.25 | $0.77 | 12.0x | -76% |
| FY1998 Q4 | - | $13.50 | $1.09 | 12.4x | -75% |
Average P/E for displayed period: 50.0x
OPCH Chart Terminal
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
Live Breakouts Feed
High-probability breakout stocks crossing their pivot across 5 pattern engines.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
28+ years return with dividends reinvested.
Peer Comparison
Compare growth, multiples, and margins vs sector.
OPCH — Frequently Asked Questions
Quick answers to the most common questions about buying OPCH stock.
What is OPCH's P/E ratio?
Option Care Health, Inc. (OPCH) trailing twelve-month P/E ratio is 22.1x, based on TTM diluted EPS of $1.43. The 5-year average P/E is 25.8x and the historical range spans 15.8x to 36.7x.
Is OPCH stock overvalued or undervalued?
OPCH trades at 22.1x P/E, near its 5-year average of 25.8x. The 30th percentile ranking within the 15.8x–36.7x historical range places valuation within normal bounds.
Is OPCH stock expensive?
OPCH is fairly valued relative to its own history. The current P/E of 22.1x is near the 5-year average of 25.8x (30th percentile of historical range).
What is OPCH's historical P/E range?
Over the past 5 years, OPCH's P/E ratio has ranged from 15.8x to 36.7x, with a median of 24.9x and an average of 25.8x. The current P/E of 22.1x places the stock at the 30th percentile of this range. Full historical data spans 1998–2026.
How does OPCH's P/E compare to the S&P 500?
OPCH trades at 22.1x P/E versus the S&P 500 median of 21.8x. The 1% premium to the market typically reflects higher expected earnings growth or quality.
How does OPCH's valuation compare to Healthcare peers?
Option Care Health, Inc. P/E of 22.1x compares to the Healthcare sector median of 24.6x. The discount suggests lower growth expectations, weaker margins, or higher perceived risk relative to peers. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.
What is OPCH's PEG ratio?
OPCH PEG ratio is N/A, based on a P/E of 22.1x and EPS growth of 3.3%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.
What is OPCH's earnings yield?
OPCH earnings yield is 4.52%, the inverse of its 22.1x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.